SCHEMBL29452452

SCHEMBL29452452

C#Cc1cc(OCCO)c(-c2c(-c3ccc(Oc4nccc(C)n4)c(F)c3)c3c(N)ncnc3n2COCC[Si](C)(C)C)cn1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
FGFR1 P11362 1/20 0.47
CYP2C9 P11712 1/20 0.47
FGFR2 P21802 1/20 0.47
FGFR4 P22455 1/20 0.47
FGFR3 P22607 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALOX5AP P20292 3/20 0.35
FEN1 P39748 3/20 0.35
FYN P06241 1/20 0.31
YES1 P07947 1/20 0.31
RPS6KB1 P23443 1/20 0.31
EPHA2 P29317 1/20 0.31
RPS6KA3 P51812 1/20 0.31
VCP P55072 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22658680 1.00 CYP3A4 (0.47) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL30390425 0.92 CYP3A4 (0.46) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL29452499 0.91 CYP3A4 (0.45) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL22658860 0.91 CYP3A4 (0.45) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL29452511 0.90 CYP3A4 (0.48) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL22658575 0.90 CYP3A4 (0.48) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL22676456 0.84 CYP3A4 (0.53) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL30303878 0.84 CYP3A4 (0.53) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL22677157 0.83 CYP3A4 (0.47) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL29407706 0.83 CYP3A4 (0.47) CYP3A4CYP2D6FGFR1CYP2C9FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3968999-A1 FGFR INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2022-03-23 EP disclosed